ACE and diabetic kidney disease: The cornerstone for the management of DKD extends beyond lowering hyperglycemia, and it includes renoprotective strategies such as the use of angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACE inhibitors) (Macisaac et al., 2014).